About DMTC
DMTC works collaboratively with many innovative Australian industry, research and government partners. Our focus is on delivering enhanced defence and national security capabilities, and strengthening Australian industrial capacity. Our approach delivers outstanding achievements in research excellence and technology adoption, backed by a best-practice quality system.
Read More
Funding injection to advance vaccine development
A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative.
Read More
